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1. ENTROl3UCTlON 
Interference with blood coagulation is one of the 
main causes of the pathological manifestation in 
snakebites by the families of Crotalidue and Viperirlrre 
[I]. Recently, another mechanism by which snakebitcs 
may interfere with hemostasis was discovered in trig- 
ramin, a naturally-occurring low molecular weight pep- 
tide from the venom of Trirneresurus gramineus [2]. 
This peptidc inhibits platelet aggregation by specifically 
and competitively inhibiting fibrinogen binding to the 
receptors associated with the GPIIb/GPIIIa complex in 
activated platelets. Having recently developed amethad 
to study the adhesion of platelets to collagen in the 
absence of platelet aggregation [3], we screened a 
number of crude snake venoms to determine whether 
any possessed proteins that inhibited platelet adhesion 
to collagen, a process thought to be mediated by recep- 
tors associated with the GPIa/GPIIa complex [4-63. 
We report here the isolation and identification of very 
similar 50 kDa proteins present in 4 different snake 
venoms which have the ability to specifically inhibit the 
adhesion of human platelets to collagen. 
2. MA’I’ERIALS AND METWQDS 
Snake venoms were purchased from Sigma and reconstituted in 
0.9% NaCl at 10 m&ml. The following venoms (all at a final concen- 
tration of lOpc& protein/ml) were screened: Agkistrodon ucutus, A. 
bifineutus, A, cotztortrixcontortrix, A. contortrix laticinctus, A. con- 
tortrix mokason, A. holys blomhoffii, A. piscivorus Ieuostomo, A. 
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pkciverrrs piscivarur, A. rhudostoma, Actrtreiaps superba, Blrls 
arietuns, Balhraps asper, B. atrax, 8, jararuea, c3. neu wiedi, 8: nwn- 
nipaf, B, sehlegrli, Bungarus jasciafw, Bungarrcs mitltkinetrcs, 
Crotalas ndumant~rts, C. atrax, C, Bosiliscirs, C. durissrrs terri/inrs, 
Drndraaspis jamesonii, Naja nretanoleura, Naja nuja atm, Ophis- 
phagrrs hatmah, Psei4dechis nusrmlis, Seprrlo,l hemuehatm, Sistirrus 
miliurirrs barbowi, Trimemrtrus graminarrs nnd Vtpcra ruselli. l”hc 
adhesion assays were performed using human platelets labeled with 
[‘H]olcic acid as described previously [3), Antagonists IO TxAa, 
platelet activating factor, scrotonin, ADP and fibrinogen (ArgGly- 
Asp-Scr) were always prcrenl. The snake venom prateins were added 
to platclct suspensions 1 mio before the additian of collagen and in- 
cubation was continued for 3 min nt 37OC. Following incubation, the 
platelet suspensions were dccantcd into a manifold containing a 
10-q nylon disk under vacuum, The disks containing the platelets 
that had adhered to collagen were rinsed and then the radioactivity 
determined. Platelet aggregation studies are described clsewhcre [7]. 
Purified proteins from the 4 snake venoms were reduced, pyri- 
dylethylated with 4-vinylpyridinc and subjected to amino acid 
analysis, A monoclonal antibody (mAb) directed against the protein 
from B. atror was prepared in mice using standard fusion and limiting 
dilution and cloning procedures 181, Hybridoma screening and titer- 
ing were conducted using ELI!% microtitrc plate assay. The mAb 
2C3 1 was developed in ascites tumors and purified using a recombi- 
nant Protein G-agarosc column. It was identified to be of the IgGl 
subclass. Western blotting of the 4 active snake venoms was pcrform- 
ed following separation by sodium dodecyl sulfate-polyacrylamidc gel 
electrophoresis (SDS-PAGE, 12070: non-reduced) as described [9]. 
After transfer to immobilot~ (Millipore), the proteins were incubated 
with mAb 2C31 followed by incubation with a secondary alkaline 
phosphatase-conjugated antibody, The blot was developed with 
5-brorr~o-4-chloro~3-indolyl-phosphate/Nitroblue tctrazolium. 
3. RESULTS 
The crude venoms from 4 snakes, three of which were 
South American vipers (8 strox, B. jaracxa and Ai 
halys blomhoffiii) and one which was a North American 
Rattlesnake (C. bmiliscus), showed strong inhibitory 
activity in the platelet adhesion assay. Several of the 
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01hrr crude VClv3rnS ceased %~on~~n~ou% phwkE aQ* 
gregt~lon even ln the prcnenec of ths rccoptsr fin= 
tagonirts which may have marked inhibitory activity in 
the adhcrion assay. 
The aetivc protein3 from the 4 inhibitory xnnke 
venoms were purified inirially by chromatoyrt%plry on ti 
Scpkadcx G~loO calumn (2 x 45 em) equilibrated tmd 
eluted with Q,9% NaCl at a flow rate of 6 ml per hour, 
In the ease of all four proteins, inhibitory activity in the 
platelet adhesion assay cluted early from this column, 
usually in IS ml, Further purKieacion of the snake 
venom proteins was aceomglishud by reversephase 
HPLC on a Vydnc C4 column (semi-preparative, I x 25 
cm) using a CiOmin linear gradient of acetonitrile in 
0.1% trifluoroacetic acid. For all four snake venom 
proteins, biological activity cluted at approximately 
70% acctonitrile in 0.1%~ trifluoroacetic acid. The 
purification of the four proteins was followed by SDS- 
PAGE, as shown for B. alrsx in Fig. I. The purified 
proteins migrated as a single band with an apparent A/1, 
of 50 kDa in both reduced and non-reduced gels, sug- 
yescing that the inhibitory protein is composed of a 
single polypeptide chain. However, after storage ac 
- 20aC for a week or more, larger aggregates of the 
venom proteins were visible, apparently reflecting 
disulfidc interchange. 
The purified proteins from the four snake venoms 
were subjected co amino acid analysis. The three South 
American venom proteins (B. atrox, B. jururuca and A. 
halys blomhoffii) exhibited a strikingly high degree of 
similarity in amino acid composition, while less 
similarity was found with C. busiliscus. In particular, 
the South American venom proteins conrained 13 
methionine residues per molecule, while the protein 
frm C. Irasl/iku~ eontwlncd only 5. ~~rnp~ri~~n af the 
$0 kDa pr~cina with other ~xateinx rova~lcd that thler 
snake Emmy prsfein~r are untraual in rhc lwro~ number 
sf c~rtciar rcnidWx they peW!4s (an af aa 
reriduel per molecule or 6.5 rrtol %), Att dcrrr* 
mine the amino acid aequanccs of the proteins purifisd, 
from 8, anox, $. jtr~~~ursl and ~4. ha& blmhqQi7 
revealed that, while they Iaeked ~a~boh~drate~ theyall 
had blocked NlWerminrl residues. t&in@ mAb X31 
raised apainst the purified B. UWJS protein, Western 
blot wna.1ysis of each of the four crude anakc venoms 
rcvcaled ZI tin& hsmsgcneoum pratein with an M, al 
approximately 50 kDa (Fig, 2). In the case of C. 
bfrs//i~cu~, larger amounts of the venom were required 
for detection by immunoblottin~ as compared co the 
other snake venoms, indicating that the inhibitory pro- 
rein in this venom was less immurroreactive, 
The purified proteins inhibited platelet adhesion In a 
competitive fashion as shown for B. srraxin Fig. 3. The 
concentration required for SW% inhibition of adhesion 
was approximately 10 @riI, or 0.2 &I assuming a 
molecular weight of 50 kDa. Increasing the preincuba- 
tion time with snake venom protein beyond one min did 
not increase the extent of inhibition (results nor shown). 
In three experiments, the purified proteins obtained 
afrer HPLC were tested for their ability to inhibi: 
platelet aggregation i  citraced platelet-rich plasma. At 
5 &ml, the B. QC~OX totally abolished platelet aggrega- 
tion induced by 1 &ml collagen but had no effect on 
the rate of platelet aggregation induced by ADP, 
epincphrine, platelet-activating factor or the thrombox- 
’ Fig. 1. Coomassie blue stain following SDS-PAGE (12%; non- Pig. 2, Western blot analysis of crude snake venoms Following SDS- 
reduced). Lane 1, molecular weight standards; lane 2, crude 5. atrox’ PAGE (12070, non-reduced). Lane 1, C. busiliscus (20 pg); lane 2; B. 
venom; lane 3, B. atrox after Sephadex G-100 column chroma- atrox (200 ng); lane 3,B. jururacu (200 ng); lane 4, A. ha/p blowhof- 
tography; lane 4, 5. alrox after HPLC. fii (200 ng), Molecular weight standards are shown on the right, 
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rclerraQ of dense pnulc ~~~~~i~u~n~$ /11], While it is 
tx~timrly reaqwl rh~f hr$-Gly-Asp cencainln~, $ep= 
cl&a. [Is], including snake vendm proreim SPA 8% 
60 ~~i~r~rn~~ [Xl, inhibit placclec a$~~~$~~i~~ by corn- 
Y! 
petitively and apeeifierlly inhibiting plateltr adkeoion ta 
Lo 
~brino$~n, until now no specif’ic inhibiraro of platelet 
4 
adhenion ce, collagen have besn described. WC have yet 
IQ determine how the snake venom proteins reported 
z 10 
here rpseifierlly inhibit plarslet adhesion co collagen 
without affercing ~~$r~~~cion induced by ocher 
agonists. Hawlrver, WC have been unable co detect pro. 
ceolycic activity in the purified protein from B. tllt~x us= 
02 3 10 $5 20 ing either ~,cneral pratein substrates (casein, aaogcasein 
and aao-csllagen) or substrates spceiEr for trypsin (N= 
&#Tll SVP bcnooyl0Arg-~rricroanilide), chymocrypsin (succinyl= 
R&L 3. GancenlrPricln-rapondc CUFW br Inhibition Urj~larak1 adhex Ala-Ala.Pro.@he.~-nitroaniiide) and COllflgWIZiS~ 
rion 10 collapcn /35rg/mtl by rhc twiliefA ~rrli~adltcrtve prefsln from (4~phcnyla~obcn;syloxy-carbonyl~Fr~-~~u-Gly-~ro~D- 
A, (I/f&V (S\bP), Arg). The possibility exists that the proteins initially 
possessed praccolycic acivity and chat ehis was lost 
beeausc of the use of trifluoroaeecic acid and 
ane mimetic SQ 26655 (Fig. 4). In addition, the acctonicrilc in the HPLC. As the SO kDr! proteins retain 
purified proteins inhibited both calcium mobilization 
and release of (?Z]seroconin in futn 2-loaded platelets 
inhibitory activity against plntclec adhesion co collagen 
wen after HPIX it seems most likely char they act by 
stimulated by collagen in the preserve of chc feedback binding co receptor sites either on platelets or on col- 
pathway antagonists (results not shown), lagen. 
The snake venom proteins described here differ from 
4. DISCUSSION 
The adhesion of platclcts CO collagen is thought co 
play a major role in hcmoscasis and thrombosis, When 
platelets adhere to collagen they release adenine 
nucleotides and amines from their dense granules and, 
in addition, arachidonic acid is liberated from mem- 
trigramin (2) in both molecular weight and amino acid 
composition. Moreover, they do not function by irr- 
teracting at the Fibrinogen receptor present on 
GPIIb/GPIIIa in activated platelets as ail of our ex- 
perimencs were performed in the presence of Arg-Giy- 
Asp-Ser, an inhibitor of this receptor. Furthermore, the 
proteins reported here differ from another inhibitor of 
e 
increase 
light 
transmission 
i 
Fig. 4. Effects of the purified snake venom protein (5 &ml) from 5. CWJX (indicated by c sign) on aggregation in human titrated platelet-rich 
plasma induced by (a) collagen (1 @/ml), (b) ADP (5 PM), (c) epinephrine (5 pM), (d) platelet-activating factor (0.25 ,uM) and (e) SQ 26655 
(0.2 ,uM). 
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¢ollalen-indu+:ed plllidet l l l r~l t l i ion recently describ- 
ed in Bot/i~opsjart~r¢i~t [1~11, ns this lalicr protein had 
a molecular wcishl or upproxim=iely |3 kDa. ln- 
teresiintlY, HRIB, a 57-60 kDa hemorrllaitic protein 
isolated from Trlm~,r~Jt,'u.~ S/avidoridis was reeendy 
cl~aracterized as beini$ it member of a new subfamily of 
metalloprotelnases [141. Additionally il~is protein con- 
tairis It domain in which the ArlI-GIx-Asp sequence is 
replaced by GIu.Ser.Glu.Cy:s, It is possible that the $0 
kDa proteins described' here contain ll metallopro. 
teinase domain at the NHa-terminus [lS] and n 
dlsintetlrin-Iike sequence in the rest ol ~ tile molecule. At. 
tempts to elucidate the mechanism oft~ction of our pro. 
reins are currently in progress. 
,~lckllow/¢rllt~lllctll~: Tll/~ ~ork wll~ ~lipporl¢ll In I'llirl hX llli~ HI l t  
((iritnl H L.~6~i71)1 find TII~ AlllCrleail I=i¢,'irl A~o~hlilon Solilllcasicrn 
Affl ltaim We ihallk Dr. Alex I~ufotkT, Dcph of tlumlln Itlolollical 
Chcmislry and Gencih:s. l./nlv~r~lly of  "l'~,~lls Mcdlcld Itrandi, 
(lalve~lon, Texas for p~rroflllilltt ih~ allltno ll~id lln~iXs~s, 
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